Neuroinflammation and Genetic Factors in Frontotemporal Dementia

Frontotemporal dementia (FTD) comprises a spectrum of neurodegenerative syndromes marked by progressive atrophy of frontal and temporal lobes, leading to deficits in behaviour, language and executive function. A growing body of evidence implicates neuroinflammation as both a driver and a consequence of proteinopathies in FTD. Activation of microglia and astrocytes accompanies deposition of tau or TDP-43 aggregates, releasing cytokines and chemokines that exacerbate synaptic loss and neuronal dysfunction. Genetic factors interweave with inflammatory pathways: expansions in C9orf72 and mutations in progranulin (GRN) or microtubule-associated protein tau (MAPT) not only alter proteostasis but also reshape innate immune responses. Genome-wide analyses reveal enrichment of immune-related loci, particularly within the human leukocyte antigen (HLA) region, suggesting that host defence genes modulate disease susceptibility and progression. Peripheral immune profiles mirror central inflammation, with shifts in monocyte subsets and elevated pro-inflammatory cytokines detectable in blood and cerebrospinal fluid. Advances in PET imaging of microglial activation and multiplex assays for cytokine panels now enable in vivo stratification of FTD subtypes by inflammatory signature. These insights open new avenues for immunomodulatory therapies and precision medicine, aiming to attenuate neuroinflammation and slow the clinical course of this heterogeneous disorder.

Research from Nature Portfolio

Recent studies have identified activation of the NLRP3 inflammasome as a key mediator of neuroinflammation in behavioural variant FTD. Analyses of serum and superior frontal cortex tissue demonstrate concordant elevations of GRO-α and interleukin-18, implicating inflammasome assembly or NF-κB signalling in cytokine dysregulation. These findings highlight the NLRP3 axis as a potential therapeutic target and support the use of peripheral cytokine panels to monitor central inflammatory processes in clinical trials.

Neuroinflammation and Genetic Factors in Frontotemporal Dementia publication trend

The graph below shows the total number of articles in neuroinflammation and genetic factors in frontotemporal dementia across all publications each year (not limited to Nature Index journals).

Technical terms

Neuroinflammation: Activation of central nervous system immune cells leading to release of cytokines, chemokines and other inflammatory mediators.

Microglial activation: Transition of microglia from a surveillant to an activated phenotype, characterised by morphological change and secretion of pro-inflammatory factors.

Inflammasome: A multiprotein complex (e.g. NLRP3) that senses cellular stress and activates caspase-1, driving production of interleukin-1β and interleukin-18.

Single nucleotide polymorphism (SNP): A single base change in DNA that may influence gene function or regulation, often investigated in genome-wide studies.

C9orf72 expansion: A hexanucleotide repeat expansion in the C9orf72 gene, the most common genetic cause of familial FTD, associated with RNA foci and dipeptide repeat protein toxicity.

Progranulin (GRN): A growth factor with anti-inflammatory and neuroprotective functions; loss-of-function mutations lead to reduced progranulin levels and increased inflammatory cytokines in FTD.

References

1. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia. Brain (2023).
2. Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival. Molecular Psychiatry (2024).
3. Peripheral inflammation in behavioural variant frontotemporal dementia: associations with central degeneration and clinical measures. Journal of Neuroinflammation (2023).
4. Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia. Scientific Reports (2023).
5. Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLOS Medicine (2018).
6. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain (2020).
7. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. Journal of Neuroinflammation (2011).
8. A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. Neurobiology of Aging (2015).